Table 1.
Summary of effect evaluation parameters of EA pretreatment against MIRI in animal experiments.
| Reference | Species | Models | Infarct reduction | Effect evaluation parameters |
|---|---|---|---|---|
| Gao et al. [22] | Rats | 30 min LADCA ligation, 15 min reperfusion | ∼44% | ST segment of ECG; cardiac arrhythmias; risk zone/infarct size |
| Huang et al. [24] | Rats | 30 min LADCA ligation, 240 min reperfusion | ∼55% | Arrhythmic; infarct size and myocardial enzymes; gene expressions genome-widely |
| Gao et al. [28] | Rats | 40 min isolated heart reduced-flow perfusion, 10 min reperfusion | No morphological study | Arrhythmia; [Ca2+]i in resting single ventricular myocyte; Cx43 protein levels in ventricular myocytes; nonphosphorylated Cx43 in ventricular myocytes |
| Shao et al. [29] | Rats | 30 min LADCA ligation, 30 min reperfusion | No morphological study | ST segment displacement value; SOD, MDA content in serum; cardiomyocyte tissue structure; ultramicrostructure of cardiomyocytes; expression of Nrf2 and HO-1 genes in myocardial tissue |
| Wang et al. [30] | Rabbits | 40 min LADCA ligation, 60 min reperfusion | No morphological study | NO, NOS content in serum; adenosine content in serum |